- Antineoplastic Agent, RET Kinase Inhibitor
- Antineoplastic Agent, Tyrosine Kinase Inhibitor
Medication Safety Issues
Pralsetinib may be confused with pazopanib, pemigatinib, pexidartinib, ponatinib, pralatrexate, ripretinib, selpercatinib.
High alert medication:
This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its lists of drug classes that have a heightened risk of causing significant patient harm when used in error.